Theravex® for Burning Mouth Syndrome

Clinical trial NCT07564843 · COMPLETED

Trial details

NCT number: NCT07564843
Sponsor: Biointelligent Technology Systems SL
Status: COMPLETED
Phase: Not Applicable
Study type: INTERVENTIONAL

Primary Burning Mouth Syndrome (BMS)

Start date: 2024-10-06
Primary completion: 2024-10-06
Enrollment: 116

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.